MedPath

Investigation to explore whether there is a synergistic effect between nicotine replacement therapy and guided bodyscanning on cigarette cravings and withdrawal symptoms in temporarily abstinent smokers. - Bodyscanning & NRT

Phase 1
Conditions
Healthy volunteers who currently smoke 10 or more cigarettes per day, for the last 3 years. The trial intends to explore whether there is a synergistic effect between the relaxation technique of guided body scanning and nicotine replacement therapy (NRT). The trial uses no products that are under development.
MedDRA version: 9.1 Level: LLT Classification code 10056484 Term: Nicotine craving
Registration Number
EUCTR2008-005363-34-GB
Lead Sponsor
niversity of Surrey
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
72
Inclusion Criteria

The principal inclusion criteria specifies that participants must be smokers aged between 18 and 65, who smoke at least ten cigarettes per day, and have done for the last three consecutive years. They must also be able to read and write in English.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

They must not be receiving treatment for mental health problems, not pregnant or currently trying to conceive.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath